Aidoc
FDA-cleared AI triage for urgent CT and X-ray findings, built on its CARE model
Overview
Aidoc is a clinical AI company whose aiOS platform runs FDA-cleared algorithms that flag urgent findings on CT and X-ray and route them to radiologists and care teams. Its CARE foundation model powers an abdominal CT triage product cleared for 14 acute indications, which became eligible for a Medicare add-on payment from October 2026. It is sold to hospitals and health systems on quoted contracts.
Pricing
Pricing shown for reference only. These figures reflect RECATOOLS research as of 14 Oct 2026 and may be out of date or incomplete. This is not financial or purchasing advice — always confirm the current price on the provider’s official website before making any decision.
Use cases
What you can produce with Aidoc
- Automatic triage of urgent findings on CT and X-ray, reordering the radiologist worklist
- Abdominal CT triage across 14 acute indications from the CARE foundation model
- Care-team notifications with mobile image review for urgent cases
- Incidental-finding capture and patient follow-up tracking
- One aiOS platform running Aidoc and third-party algorithms with performance monitoring
- Medicare NTAP eligibility for qualifying inpatient CARE Body CT Multi-Triage use
ASEAN Perspective
Aidoc in Southeast Asia
Aidoc's APAC presence is currently concentrated in Australia and New Zealand through its Integral Diagnostics partnership (600,000+ cases since 2019), with the company's own materials noting broader "Asia" deployments without naming specific ASEAN facilities. Southeast Asian public hospitals — which handle heavy emergency CT volumes in countries such as Indonesia, Vietnam, and the Philippines — could benefit from acute-triage AI, but Aidoc's enterprise pricing model and US/EU regulatory focus (FDA and CE marks rather than local equivalents like Singapore HSA or Malaysia MDA) limit near-term accessibility. ASEAN private hospital groups and teleradiology networks are more likely early adopters, contingent on Aidoc prioritising regional regulatory submissions and local-language support.
Aidoc is one of the most established radiology AI vendors: 35 FDA 510(k) clearances, a foundation-model triage product covering 14 abdominal CT indications, and from October 2026 a Medicare add-on payment that helps US hospitals recover part of the cost. aiOS also gives health systems one place to run and monitor several AI tools.
Performance figures come from Aidoc's own clearance studies, and draft-report generation is still a designation, not a cleared product. Pricing is quote-only and aimed at hospital systems. Worth shortlisting for large imaging departments; not for small clinics.
What we found
Aidoc sells clinical AI to hospitals, starting with radiology triage. Its software reads CT and X-ray studies in the background and pushes suspected urgent findings, such as brain bleeds, pulmonary embolism and cervical-spine fractures, up the radiologist's worklist and out to the treating team. It all runs on aiOS, Aidoc's platform for deploying and governing its own algorithms and vetted third-party ones inside existing imaging and records systems. The FDA's 510(k) database lists 35 clearances under the Aidoc name since 2018, four of them between January and May 2026, and a single clearance can cover several findings.
The centrepiece now is CARE, Aidoc's in-house foundation model. In January 2026 the FDA cleared a CARE-based abdominal CT triage product covering 14 acute indications in one workflow, 11 of them newly cleared. Aidoc reports mean sensitivity of 97% and specificity of 98% from the clearance study; those are vendor-reported figures, not the peer-reviewed results earlier versions of this page described. In August CMS approved a Medicare New Technology Add-on Payment for CARE Body CT Multi-Triage, so from 1 October 2026 US hospitals can bill an add-on for eligible inpatient use. In June the FDA gave Breakthrough Device Designation to First Read, which drafts preliminary report text from chest radiographs; it has not been cleared.
Funding is large. In April 2026 Goldman Sachs Alternatives led a $150 million Series E with General Catalyst, SoftBank Vision Fund 2 and NVentures, taking total funding past $500 million. In August twelve US health systems, including Cedars-Sinai, Mount Sinai and Northwell, formed a Diagnostic AI Consortium with Aidoc.
Scale claims differ between pages: press releases say nearly 2,000 hospitals, while the homepage says more than 1,600 medical centres. Prices are not published and are quoted per health system. Aidoc is built for hospital IT and procurement teams; small practices are not its market.
Compiled by RECATOOLS from public sources: vendor documentation and pricing, code repositories and published reporting.
Notable facts
- All three co-founders are graduates of the IDF's elite Talpiot technology programme, which selects fewer than 30 candidates per year.
- Aidoc's CARE foundation model was the first AI system to receive FDA clearance for detecting 14 different acute CT findings using a single unified model, announced January 2026.
- Aidoc is the only AI vendor integrated directly into Epic's Radiant worklist via the App Orchard, meaning radiologists get AI flags without leaving their existing workflow.
- NVIDIA's venture arm NVentures joined both the 2025 growth round and the 2026 Series E, signalling alignment with NVIDIA's medical imaging GPU infrastructure strategy.
Frequently asked questions
About this listing
This entry was compiled from publicly available data including Aidoc's official website, press releases, documentation, and reputable third-party publications. RECATOOLS is not affiliated with Aidoc unless explicitly stated.
Third-party AI tools update their pricing, features, availability, and policies frequently. Information here may be outdated by the time you read this — we make reasonable efforts to keep listings current, but cannot guarantee absolute accuracy.
For the latest details, please refer to Aidoc directly →
Spotted something out of date? Suggest an update →
More in Healthcare
